Advertisement
Journal Home
Search for

926 Periodical Search Results

You searched for "advanced" AND "breast cancer" OR "breast neoplasms" OR "carcinoma of breast" OR "malignant tumor of breast" OR "malignant tumour of breast" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 926 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. The clinical efficacy of cytotoxic agents in locally advanced or metastatic breast cancer patients pretreated with an anthracycline and a taxane: A systematic review , 17 July 2009
    Jacek Jassem, Christopher Carroll, Sue E. Ward, Emma Simpson, Daniel Hind
    European Journal of Cancer
    November 2009 (Vol. 45, Issue 16, Pages 2749-2758)
    Abstract | Full Text | Full-Text PDF (174 KB)

  1. Toremifene: where do we stand?
    J Mäenpää, K Holli, T Pasanen
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 61-62)
    Abstract | Full Text | Full-Text PDF (67 KB)

  1. Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women
    I. Vergote, J. Bonneterre, B. Thürlimann, J. Robertson, M. Krzakowski, L. Mauriac, L. Koralewski, A. Webster, M. Steinberg, M. von Euler, on behalf of the Arimidex Study Group
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 84-85)
    Abstract | Full Text | Full-Text PDF (68 KB)

  1. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
    M.S. Aapro, D.A. Cameron, R. Pettengell, J. Bohlius, J. Crawford, M. Ellis, N. Kearney, G.H. Lyman, V.C. Tjan-Heijnen, J. Walewski, D.C. Weber, C. Zielinski, European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party
    European Journal of Cancer
    October 2006 (Vol. 42, Issue 15, Pages 2433-2453)
    Abstract | Full Text | Full-Text PDF (309 KB)

  1. Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography
    R.J Burcombe, A Makris, M Pittam, J Lowe, J Emmott, W.L Wong
    European Journal of Cancer
    2002 (Vol. 38, Issue 3, Pages 375-379)
    Abstract | Full Text | Full-Text PDF (93 KB)

  1. A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancer
    Manuela R.E. Eicher, Sara Marquard, Stefan Aebi
    European Journal of Cancer
    December 2006 (Vol. 42, Issue 18, Pages 3117-3126)
    Abstract | Full Text | Full-Text PDF (173 KB)

  1. A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer
    W. Jonat, A. Howell, C. Blomqvist, W. Eiermann, G. Winblad, C. Tyrrell, L. Mauriac, H. Roche, S. Lundgren, R. Hellmund, M. Azab
    European Journal of Cancer
    March 1996 (Vol. 32, Issue 3, Pages 404-412)
    Abstract | Abstract + References | Full-Text PDF (1099 KB)

  1. Will children with cancer benefit from the new European Paediatric Medicines Regulation? , 06 May 2009
    Gilles Vassal
    European Journal of Cancer
    June 2009 (Vol. 45, Issue 9, Pages 1535-1546)
    Abstract | Full Text | Full-Text PDF (156 KB)

  1. Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer
    M Namer, P Soler-Michel, F Turpin, P Chinet-Charrot, C de Gislain, P Pouillart, T Delozier, E Luporsi, P.L Etienne, S Schraub, J.C Eymard, D Serin, G Ganem, G Calais, P Maillart, P Colin, V Trillet-Lenoir, G Prevost, D Tigaud, P Clavère, P Marti, G Romieu, J.L Wendling
    European Journal of Cancer
    June 2001 (Vol. 37, Issue 9, Pages 1132-1140)
    Abstract | Full Text | Full-Text PDF (177 KB)

  1. Long-term survival of women with breast cancer in New South Wales
    Richard R. Taylor, Philip P. Davis, John J. Boyages
    European Journal of Cancer
    January 2003 (Vol. 39, Issue 2, Pages 215-222)
    Abstract | Full Text | Full-Text PDF (161 KB)

  1. Preclinical studies of erythropoietin receptor expression in tumour cells: Impact on clinical use of erythropoietic proteins to correct cancer-related anaemia
    Anders Österborg, Matti Aapro, Paul Cornes, Anton Haselbeck, Colin R.W. Hayward, Wolfgang Jelkmann
    European Journal of Cancer
    February 2007 (Vol. 43, Issue 3, Pages 510-519)
    Abstract | Full Text | Full-Text PDF (202 KB)

  1. Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer—a randomised study with more than 10 years follow-up from the danish breast cancer cooperative group
    M Andersson, E Lindegaard Madsen, M Overgaard, C Rose, P Dombernowsky, H.T Mouridsen, Danish Breast Cancer Cooperative Group (DBCG)
    European Journal of Cancer
    January 1999 (Vol. 35, Issue 1, Pages 39-46)
    Abstract | Full Text | Full-Text PDF (117 KB)

  1. Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients?
    L.M. Oldervoll, S. Kaasa, M.J. Hjermstad, J.Å. Lund, J.H. Loge
    European Journal of Cancer
    May 2004 (Vol. 40, Issue 7, Pages 951-962)
    Abstract | Full Text | Full-Text PDF (260 KB)

  1. Male breast cancer: a review of the literature
    F Ravandi-Kashani, T.G Hayes
    European Journal of Cancer
    August 1998 (Vol. 34, Issue 9, Pages 1341-1347)
    Abstract | Full Text | Full-Text PDF (82 KB)

  1. Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trial
    M. Andersson, C. Kamby, M.-B. Jensen, H. Mouridsen, B. Ejlertsen, P. Dombernowsky, C. Rose, S. Cold, M. Overgaard, J. Andersen, M. Kjær, on behalf of the Danish Breast Cancer Co-operative Group
    European Journal of Cancer
    November 1999 (Vol. 35, Issue 12, Pages 1659-1666)
    Abstract | Full Text | Full-Text PDF (127 KB)

  1. Improved outcome from substituting methotrexate with epirubicin: Results from a randomised comparison of CMF versus CEF in patients with primary breast cancer
    Bent Ejlertsen, Henning T. Mouridsen, Maj-Britt Jensen, Jørn Andersen, Søren Cold, Per Edlund, Marianne Ewertz, Brita B. Jensen, Claus Kamby, Bo Nordenskjold, Jonas Bergh
    European Journal of Cancer
    March 2007 (Vol. 43, Issue 5, Pages 877-884)
    Abstract | Full Text | Full-Text PDF (229 KB)

  1. Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: Further results from a randomised controlled trial , 04 June 2007
    Christine Müller, Angelika Caputo, Martin Schumacher, Günter Raab, Martin Schütte, Jörn Hilfrich, Manfred Kaufmann, Gunter von Minckwitz
    European Journal of Cancer
    July 2007 (Vol. 43, Issue 11, Pages 1654-1661)
    Abstract | Full Text | Full-Text PDF (188 KB)

  1. Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial
    M Kaufmann, E Bajetta, L.Y Dirix, L.E Fein, S.E Jones, J Cervek, C Fowst, A Polli, E Di Salle, G Massimini, G Piscitelli, for the Exemestane Study Group
    European Journal of Cancer
    September 2000 (Vol. 36Supplement 4, Pages 86-87)
    Abstract | Full Text | Full-Text PDF (68 KB)

  1. Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trial
    A Decensi, R Torrisi, V Fontana, A Barreca, P Ponzani, F Pensa, S Parodi, A Costa
    European Journal of Cancer
    June 1998 (Vol. 34, Issue 7, Pages 999-1003)
    Abstract | Full Text | Full-Text PDF (87 KB)

  1. Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: Results from an integrated analysis , 25 December 2008
    G. von Minckwitz, M. Schwenkglenks, T. Skacel, G.H. Lyman, A. Lopez Pousa, P. Bacon, V. Easton, M.S. Aapro
    European Journal of Cancer
    March 2009 (Vol. 45, Issue 4, Pages 608-617)
    Abstract | Full Text | Full-Text PDF (225 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 926 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement